Next Generation Sequencers (NGS) Market

Next Generation Sequencers (NGS) Market (Product: Benchtop Sequencers and Floor Standing Sequencers; Technology: WGS, Whole Exome Sequencing, and Targeted Sequencing & Resequencing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Next Generation Sequencers (NGS) Market Outlook 2031

  • The industry was valued at US$ 1.2 Bn in 2022
  • It is projected to grow at a CAGR of 8.3% from 2023 to 2031 and reach more than US$ 2.4 Bn by the end of 2031

Analyst Viewpoint

Advancements in sequencing technologies is driving the global next generation sequencers (NGS) market. NGS technologies have emerged as a cornerstone in deciphering the complexities of genomics by enabling rapid and cost-effective sequencing of DNA and RNA. Increase in demand for personalized medicine and precision diagnostics is propelling market expansion. Furthermore, surge in funding for and awareness about advanced genomic technologies is expected to bolster the global next generation sequencers (NGS) industry size during the forecast period.

Advancements in sequencing technologies, such as improved read lengths, enhanced accuracy, and reduced costs per base pair offer lucrative opportunities to market players. Furthermore, companies are focusing on collaborations and partnerships with research institutions in order to develop more user-friendly and automated NGS platforms.

However, challenges such as data management, standardization of protocols, and ethical concerns related to genetic privacy is likely to restrain the global next generation sequencers (NGS) market in the near future.

Next Generation Sequencers Market

Global Next Generation Sequencers (NGS) Market Overview

Next Generation Sequencers (NGS) represent a breakthrough in DNA sequencing technology, offering a departure from traditional methods. NGS platforms employ highly parallelized approaches, enabling simultaneous sequencing of millions of DNA fragments. This capability results in significantly enhanced throughput, allowing for the rapid and cost-effective analysis of genetic material.

NGS technologies leverage diverse sequencing methodologies, including sequencing-by-synthesis, ion semiconductor sequencing, and single-molecule real-time sequencing. The high-throughput nature of NGS has transformed genomics research by facilitating comprehensive analyses of entire genomes, exomes, or specific target regions.

This versatility has extended applications across various domains, including basic research, clinical diagnostics, personalized medicine, and agricultural genomics.

The ongoing evolution of NGS platforms continues to improve factors such as accuracy, read length, and cost-effectiveness, establishing them as pivotal tools for unraveling the complexities of genetic information and advancing genomics research.

Next generation sequencers (NGS) has emerged as a dynamic and rapidly evolving sector within the biotechnology industry. The market has witnessed substantial growth due to the widespread adoption of NGS platforms across various research, clinical, and industrial applications.

Researchers and healthcare professionals leverage the high-throughput capabilities of NGS for diverse purposes, including genomics research, personalized medicine, clinical diagnostics, and agricultural genomics.

Advancements in Sequencing Technologies Fueling Market Progress

Advancements in sequencing technologies are driving the global next generation sequencers (NGS) market demand. Relentless pursuit of innovation in this domain has paved the way for unprecedented improvements in sequencing efficiency, accuracy, and cost-effectiveness. The evolution from traditional Sanger sequencing to state-of-the-art NGS platforms has been marked by breakthroughs in various aspects of sequencing technologies.

One pivotal advancement is the development of massively parallel sequencing techniques, enabling the simultaneous analysis of millions of DNA fragments. This parallelization has significantly expedited the sequencing process, allowing for rapid generation of large-scale genomic datasets.

Advancements in base-calling algorithms and error correction methodologies have substantially enhanced the accuracy of sequencing results. This improvement is particularly crucial in applications such as clinical diagnostics and personalized medicine, where precision is paramount.

Advent of single-molecule sequencing technologies has ushered in a new era in genomics. Technologies such as nanopore sequencing and single-molecule real-time (SMRT) sequencing offer the ability to directly read individual DNA molecules without the need for amplification. This not only reduces the risk of bias introduced during amplification, but also facilitates the detection of epigenetic modifications, providing a more comprehensive understanding of the genome.

Miniaturization and automation have played pivotal roles in advancing sequencing technologies. Development of microfluidic devices and integrated systems has led to higher throughput and reduced costs per base pair sequenced. These technological strides have made NGS more accessible across various research domains, fueling its widespread adoption.

Collectively, the market is driven by continuous advancements in sequencing technologies. The collective impact of parallelization, improved accuracy, single-molecule sequencing, and miniaturization has not only revolutionized genomic research, but has also expanded the scope of applications in fields ranging from clinical diagnostics to agriculture and beyond. As these technologies continue to mature, the next generation sequencers (NGS) market is poised for sustained growth and transformative impact on diverse scientific endeavors.

Increase in Funding and Awareness Fueling Market Development

The burgeoning demand for advanced genomic technologies has stimulated a surge in funding from governmental bodies, private investors, and research institutions. This influx of financial support is instrumental in fostering research & development endeavors aimed at enhancing NGS technologies, thereby fueling innovation and expanding the next generation sequencers (NGS) market landscape.

Rise in awareness and recognition of the transformative potential of NGS technologies across diverse sectors, including healthcare, agriculture, and research, contribute significantly to market expansion.

As stakeholders become increasingly cognizant of the advantages offered by NGS, there is a rising trend of adoption in clinical diagnostics, personalized medicine, and precision agriculture. The recognition of NGS as a powerful tool for deciphering complex biological information is driving the global next generation sequencers (NGS) industry growth.

Alignment of funding initiatives with awareness campaigns creates a synergistic effect, fostering a conducive environment for market development. Initiatives that aim to educate stakeholders about the benefits and applications of NGS technologies not only enhance market penetration, but also contribute to building a robust ecosystem for continued advancements.

Collaborative efforts between industry players, research institutions, and regulatory bodies, facilitated by increased funding, promote the dissemination of knowledge and best practices. The interplay of increased funding and heightened awareness is expected to be a dynamic force propelling the next generation sequencers (NSG) market.

This symbiotic relationship not only accelerates technological advancements, but also cultivates a broader understanding of the potential applications of NGS across various domains. As financial support continues to pour into the sector and awareness campaigns gain momentum, the market is poised for sustained growth and innovation.

Compact Size, Ease of Use, and Cost-effectiveness Driving Demand for Benchtop Sequencers

In terms of product, the benchtop sequencers segment accounted for the largest global next generation sequencers (NGS) market share in 2022. These devices are characterized by compact size, ease of use, and cost-effectiveness, and have emerged as the preferred choice for researchers and laboratories aiming to streamline sequencing processes.

Smaller footprint of benchtop sequencers allows for efficient utilization of laboratory space, a critical consideration in resource optimization. Additionally, these sequencers offer quicker turnaround times and lower initial investment requirements compared to their floor standing counterparts, making them more accessible to a wider range of research institutions.

Dominance of the benchtop sequencers segment can be ascribed to advancements in sequencing technologies that have empowered these compact devices to deliver high-throughput results with remarkable accuracy.

Researchers appreciate the flexibility and scalability offered by benchtop sequencers, allowing them to adapt to various experimental demands seamlessly. The user-friendly interfaces of these sequencers further contribute to their popularity, enabling researchers with diverse skill sets to efficiently operate and interpret results. Hence, benchtop sequencers have become integral to a multitude of applications, ranging from clinical diagnostics to agricultural genomics.

Regional Outlook

North America's dominance of the global next generation sequencers (NGS) market can be ascribed to several key factors. The region boasts a robust research & development infrastructure, with numerous well-established biotechnology and pharmaceutical companies leading innovation in genomics. These entities invest significantly in cutting-edge technologies, driving demand for NGS platforms.

North America also benefits from high level of government support for genomics research. Federal funding and grants contribute significantly to advancements in genomic medicine and personalized healthcare, fueling the adoption of NGS technologies. The presence of world-renowned research institutions and academic centers also plays a pivotal role in shaping the next generation sequencers (NGS) market in the region.

A mature healthcare system in North America facilitates widespread adoption of NGS in clinical settings. The region's well-developed regulatory framework ensures compliance with standards, fostering a favorable environment for the commercialization of NGS products.

Collaborations between industry players and academic institutions further accelerate the development and application of NGS technologies. This collaborative approach enhances knowledge transfer and accelerates the integration of NGS into routine clinical practices.

As per next generation sequencers (NGS) market forecast, Asia Pacific is projected to be the fastest growing region during forecast period. This is ascribed to increase in demand for personalized medicine and genomic research, bolstered by rise in awareness about the potential applications of NGS technologies.

Additionally, the region benefits from robust government initiatives and investments in genomics and biotechnology research, fostering a conducive environment for NGS market expansion.

Asia Pacific has a large and diverse population, contributing to a vast pool of genomic data that fuels research and development in the NGS sector. Collaborative efforts between academic institutions, research organizations, and industry players in the region have also played a pivotal role in advancing NGS technologies.

The region's growing healthcare infrastructure and adoption of cutting-edge technologies also contribute significantly to the escalating demand for NGS solutions, propelling Asia Pacific to the forefront of the next generation sequencers (NGS) market.

Analysis of Key Players

This report provides profiles of leading players operating in the global next generation sequencers (NGS) market. These players engage in mergers & acquisitions, strategic collaborations, and new product launches to expand presence and increase share.

Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Complete Genomics Incorporated, Vela Diagnostics, Oxford Nanopore Technologies plc, Singular Genomics Systems, Inc., HTG Molecular Diagnostics, Inc., and Revvity are the prominent players in the market.

Key Developments in Global Next Generation Sequencers (NGS) Market

  • In October 2023, Revvity, Inc. and Element Biosciences, Inc., a developer of the AVITI System, an innovative and emerging genomic sequencing platform, announced a collaboration to introduce workflow solutions that save time and effort required for genomic analysis of samples. This collaboration helps to elevate the overall customer experience by providing compelling application-specific data, stronger support and easier access to the critical components necessary for a lab to go from sample to result.
  • In April 2022, Thermo Fisher Scientific launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in one day. The platform is designed for clinical laboratories and enables users to perform diagnostic testing and clinical research on a single instrument.

The next generation sequencers (NGS) market report profiles the top players based on various factors including a company overview, financial summary, strategies, product portfolio, segments, and recent advancements.

Global Next Generation Sequencers (NGS) Market Snapshot

Attribute Detail
Size in 2022 US$ 1.2 Bn
Forecast (Value) in 2031 More than US$ 2.4 Bn
Growth Rate (CAGR) 8.3%
Forecast Period 2023-2031
Historical Data Available for 2017-2022
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional-level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes an overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • Product
    • Benchtop Sequencers
    • Floor Standing Sequencers
  • Technology
    • WGS
    • Whole Exome Sequencing
    • Targeted Sequencing & Resequencing
  • Application
    • Oncology
    • Infectious Diseases
    • Reproductive Health
    • Metagenomics, Epidemiology, and Drug Development
    • Consumer Genomics
  • End-user
    • Academic Research
    • Clinical Research
    • Hospitals & Clinics
    • Pharma & Biotech Entities
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences
  • Complete Genomics Incorporated
  • Vela Diagnostics
  • Oxford Nanopore Technologies plc.
  • Singular Genomics Systems, Inc.
  • HTG Molecular Diagnostics, Inc.
  • Revvity
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global next generation sequencers (NGS) market in 2022?

It was valued at US$ 1.2 Bn in 2022

How big will the next generation sequencers (NGS) business be in 2031?

It is projected to reach more than US$ 2.4 Bn by 2031

What will be the CAGR of the next generation sequencers (NGS) industry during the forecast period?

The CAGR is anticipated to be 8.3% from 2023 to 2031

Which was leading next generation sequencers (NGS) segment in 2022?

The benchtop sequencers product segment accounted for the largest share in 2022

Which region will account for major share of the next generation sequencers (NGS) sector during the forecast period?

North America is anticipated to account for the leading share during the forecast period.

Who are the prominent manufacturers of next generation sequencers (NGS)?

Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Complete Genomics Incorporated, Vela Diagnostics, Oxford Nanopore Technologies plc, Singular Genomics Systems, Inc., HTG Molecular Diagnostics, Inc., and Revvity.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Next Generation Sequencers (NGS) Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Regulatory Scenario

        5.3. COVID-19 Pandemic Impact on Industry

    6. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Benchtop Sequencers

            6.3.2. Floor Standing Sequencers

        6.4. Market Attractiveness Analysis, by Product

    7. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Oncology

            7.3.2. Infectious Diseases

            7.3.3. Reproductive Health

            7.3.4. Metagenomics, Epidemiology, and Drug Development

            7.3.5. Consumer Genomics

        7.4. Market Attractiveness Analysis, by Application

    8. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Technology

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Technology, 2017–2031

            8.3.1. WGS

            8.3.2. Whole Exome Sequencing

            8.3.3. Targeted Sequencing & Resequencing

        8.4. Market Attractiveness Analysis, by Technology

    9. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Academic Research

            9.3.2. Clinical Research

            9.3.3. Hospitals & Clinics

            9.3.4. Pharma & Biotech Entities

            9.3.5. Others

        9.4. Market Attractiveness Analysis, by End-user

    10. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness Analysis, by Region

    11. North America Next Generation Sequencers (NGS) Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Benchtop Sequencers

            11.2.2. Floor Standing Sequencers

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Oncology

            11.3.2. Infectious Diseases

            11.3.3. Reproductive Health

            11.3.4. Metagenomics, Epidemiology, and Drug Development

            11.3.5. Consumer Genomics

        11.4. Market Value Forecast, by Technology, 2017–2031

            11.4.1. WGS

            11.4.2. Whole Exome Sequencing

            11.4.3. Targeted Sequencing & Resequencing

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Academic Research

            11.5.2. Clinical Research

            11.5.3. Hospitals & Clinics

            11.5.4. Pharma & Biotech Entities

            11.5.5. Others

        11.6. Market Value Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Product

            11.7.2. By Application

            11.7.3. By Technology

            11.7.4. By End-user

            11.7.5. By Country

    12. Europe Next Generation Sequencers (NGS) Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Benchtop Sequencers

            12.2.2. Floor Standing Sequencers

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Oncology

            12.3.2. Infectious Diseases

            12.3.3. Reproductive Health

            12.3.4. Metagenomics, Epidemiology, and Drug Development

            12.3.5. Consumer Genomics

        12.4. Market Value Forecast, by Technology, 2017–2031

            12.4.1. WGS

            12.4.2. Whole Exome Sequencing

            12.4.3. Targeted Sequencing & Resequencing

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Academic Research

            12.5.2. Clinical Research

            12.5.3. Hospitals & Clinics

            12.5.4. Pharma & Biotech Entities

            12.5.5. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Product

            12.7.2. By Application

            12.7.3. By Technology

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific Next Generation Sequencers (NGS) Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Benchtop Sequencers

            13.2.2. Floor Standing Sequencers

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Oncology

            13.3.2. Infectious Diseases

            13.3.3. Reproductive Health

            13.3.4. Metagenomics, Epidemiology, and Drug Development

            13.3.5. Consumer Genomics

        13.4. Market Value Forecast, by Technology, 2017–2031

            13.4.1. WGS

            13.4.2. Whole Exome Sequencing

            13.4.3. Targeted Sequencing & Resequencing

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Academic Research

            13.5.2. Clinical Research

            13.5.3. Hospitals & Clinics

            13.5.4. Pharma & Biotech Entities

            13.5.5. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. By Product

            13.7.2. By Application

            13.7.3. By Technology

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Latin America Next Generation Sequencers (NGS) Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2017–2031

            14.2.1. Benchtop Sequencers

            14.2.2. Floor Standing Sequencers

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Oncology

            14.3.2. Infectious Diseases

            14.3.3. Reproductive Health

            14.3.4. Metagenomics, Epidemiology, and Drug Development

            14.3.5. Consumer Genomics

        14.4. Market Value Forecast, by Technology, 2017–2031

            14.4.1. WGS

            14.4.2. Whole Exome Sequencing

            14.4.3. Targeted Sequencing & Resequencing

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Academic Research

            14.5.2. Clinical Research

            14.5.3. Hospitals & Clinics

            14.5.4. Pharma & Biotech Entities

            14.5.5. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. By Product

            14.7.2. By Application

            14.7.3. By Technology

            14.7.4. By End-user

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Next Generation Sequencers (NGS) Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product, 2017–2031

            15.2.1. Benchtop Sequencers

            15.2.2. Floor Standing Sequencers

        15.3. Market Value Forecast, by Application, 2017–2031

            15.3.1. Oncology

            15.3.2. Infectious Diseases

            15.3.3. Reproductive Health

            15.3.4. Metagenomics, Epidemiology, and Drug Development

            15.3.5. Consumer Genomics

        15.4. Market Value Forecast, by Technology, 2017–2031

            15.4.1. WGS

            15.4.2. Whole Exome Sequencing

            15.4.3. Targeted Sequencing & Resequencing

        15.5. Market Value Forecast, by End-user, 2017–2031

            15.5.1. Academic Research

            15.5.2. Clinical Research

            15.5.3. Hospitals & Clinics

            15.5.4. Pharma & Biotech Entities

            15.5.5. Others

        15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Market Attractiveness Analysis

            15.7.1. By Product

            15.7.2. By Application

            15.7.3. By Technology

            15.7.4. By End-user

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (by tier and size of companies)

        16.2. Market Share Analysis, by Company (2022)

        16.3. Company Profiles

            16.3.1. Illumina, Inc.

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Thermo Fisher Scientific, Inc.

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Pacific Biosciences

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. Complete Genomics Incorporated

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Vela Diagnostics

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. Oxford Nanopore Technologies plc.

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. Singular Genomics Systems, Inc.

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. HTG Molecular Diagnostics, Inc.

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. Revvity

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

    List of Tables

    Table 01: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 02: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 03: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 04: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 05: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Region, 2017-2031

    Table 06: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country, 2017-2031

    Table 07: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 08: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 09: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 10: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 11: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 12: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 13: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 14: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 15: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 16: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 17: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 18: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 19: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 20: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 21: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 23: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 24: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 25: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 26: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 27: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 28: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 29: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 30: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global Next Generation Sequencers (NGS) Market Size, by Product, 2022

    Figure 02: Global Next Generation Sequencers (NGS) Market Share (%), by Product, 2022

    Figure 03: Global Next Generation Sequencers (NGS) Market Size, by Application, 2022

    Figure 04: Global Next Generation Sequencers (NGS) Market Share (%), by Application, 2022

    Figure 05: Global Next Generation Sequencers (NGS) Market Size, by Technology, 2022

    Figure 06: Global Next Generation Sequencers (NGS) Market Share (%), by Technology, 2022

    Figure 07: Global Next Generation Sequencers (NGS) Market Size, by End-user, 2022

    Figure 08: Global Next Generation Sequencers (NGS) Market Share (%), by End-user, 2022

    Figure 09: Global Next Generation Sequencers (NGS) Market, by Region (2022 and 2031)

    Figure 10: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, 2017–2031

    Figure 11: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

    Figure 12: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022

    Figure 13: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2031

    Figure 14: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023–2031

    Figure 15: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 16: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022

    Figure 17: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2031

    Figure 18: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023–2031

    Figure 19: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

    Figure 20: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022

    Figure 21: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2031

    Figure 22: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 23: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

    Figure 24: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022

    Figure 25: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2031

    Figure 26: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 27: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031

    Figure 28: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2022

    Figure 29: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2031

    Figure 30: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Region, 2023–2031

    Figure 31: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 32: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by Country, 2022 and 2031

    Figure 33: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country, 2023–2031

    Figure 34: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

    Figure 35: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

    Figure 36: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 37: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-31

    Figure 38: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

    Figure 39: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-31

    Figure 40: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

    Figure 41: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 42: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 43: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 44: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 45: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

    Figure 46: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

    Figure 47: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 48: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031

    Figure 49: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

    Figure 50: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 51: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

    Figure 52: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 53: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 54: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 55: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

    Figure 57: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

    Figure 58: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 59: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031

    Figure 60: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

    Figure 61: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 62: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

    Figure 63: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 64: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 65: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 66: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 67: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

    Figure 68: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

    Figure 69: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 70: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031

    Figure 71: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

    Figure 72: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 73: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

    Figure 74: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 75: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 76: Middle East & Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 77: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 78: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

    Figure 79: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

    Figure 80: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 81: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031

    Figure 82: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

    Figure 83: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 84: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

    Figure 85: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved